Down-regulated of IL-6 let host vulnerable to infection, subsequently raise concern on recurrence of leprosy clinical manifestations and other diseases.[49–51] But during 28 days safety monitoring, the onset of vaccination did not result in leprosy reactions or any other safety event. Here, IL6 is linked to leprosy.